Page last updated: 2024-08-25

9-aminocamptothecin and Cancer of Lung

9-aminocamptothecin has been researched along with Cancer of Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL1
Ansari, RH; Fishkin, PA; Golomb, HM; Hoffman, PC; Klepsch, A; Krauss, S; Lad, TE; Masters, GA; Ratain, MJ; Sciortino, DF; Vokes, EE1
Lad, TE; Minami, H; Nicholas, MK; Ratain, MJ; Vokes, EE1
Arrieta, R; Golomb, HM; Gordon, GS; Hoffman, PC; Krauss, S; Mauer, AM; Rudin, CM; Vokes, EE; Watson, S1

Trials

3 trial(s) available for 9-aminocamptothecin and Cancer of Lung

ArticleYear
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:10

    Topics: Aged; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome

1998
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:6

    Topics: Adult; Aged; Anticonvulsants; Blood Cell Count; Brain Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Glioma; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Logistic Models; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged

1999
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.
    Investigational new drugs, 2001, Volume: 19, Issue:4

    Topics: Aged; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Survival Rate; Time Factors; Topoisomerase I Inhibitors; Treatment Outcome

2001

Other Studies

2 other study(ies) available for 9-aminocamptothecin and Cancer of Lung

ArticleYear
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous

1991
Clinical trials referral resource. Clinical trials with 9-aminocamptothecin.
    Oncology (Williston Park, N.Y.), 1995, Volume: 9, Issue:8

    Topics: Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Colonic Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neutropenia

1995